scholarly article | Q13442814 |
P50 | author | Antonino Tuttolomondo | Q41452432 |
Antonio Pinto | Q48357572 | ||
Alessandra Casuccio | Q56615493 | ||
Giuliana Guggino | Q56810321 | ||
P2093 | author name string | Irene Simonetta | |
Rosaria Pecoraro | |||
Valentina Arnao | |||
Rosario Maugeri | |||
Domenico Di Raimondo | |||
Giuseppe Clemente | |||
Carlo Maida | |||
Vittoriano Della Corte | |||
Carmelo Buttà | |||
Rosario Squatrito | |||
Rosario Squadrito | |||
P2860 | cites work | Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment | Q22306370 |
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells | Q33806613 | ||
Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia | Q33834648 | ||
Cerebral vascular accidents in patients over the age of 60. II. Prognosis | Q34241339 | ||
The TIMPs tango with MMPs and more in the central nervous system | Q35613209 | ||
Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke | Q35802442 | ||
Multiple roles for MMPs and TIMPs in cerebral ischemia | Q36104645 | ||
Stroke and T-cells | Q36295987 | ||
Inflammation following stroke. | Q36367229 | ||
Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation | Q36371682 | ||
Experience from a multicentre stroke register: a preliminary report | Q36630179 | ||
Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression | Q37206108 | ||
Inflammation in ischemic stroke subtypes | Q37990567 | ||
Fetuin-A and CD40 L plasma levels in acute ischemic stroke: differences in relation to TOAST subtype and correlation with clinical and laboratory variables. | Q39952070 | ||
Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events | Q40166868 | ||
Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence | Q40951277 | ||
Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients | Q41024041 | ||
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes | Q42628689 | ||
Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings | Q42631372 | ||
Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. | Q43467896 | ||
Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results | Q43847071 | ||
Double-blind multicenter trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical use. | Q43993195 | ||
Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. | Q44207356 | ||
Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial | Q46414622 | ||
Increased cytokine release from peripheral blood cells after acute stroke. | Q48118212 | ||
Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer. | Q48127665 | ||
Can we talk about CD4+CD28- lymphocytes as a risk factor for ischemic stroke? | Q48177039 | ||
Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetic state. | Q48402518 | ||
Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification. | Q48458967 | ||
Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site | Q48479997 | ||
Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype | Q48611585 | ||
Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells | Q56908440 | ||
Perturbation of the T-Cell Repertoire in Patients With Unstable Angina | Q58230319 | ||
Measurements of acute cerebral infarction: a clinical examination scale | Q69660651 | ||
Antigen-specific functions of a CD4+ subset of human T lymphocytes with granular morphology | Q70278178 | ||
Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial disease | Q71533366 | ||
Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion | Q71669781 | ||
Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity | Q74392872 | ||
Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF) | Q79778200 | ||
Elevated pro-inflammatory CD4+CD28- lymphocytes and stroke recurrence and death | Q80908162 | ||
Differential pathways govern CD4+ CD28- T cell proinflammatory and effector responses in patients with coronary artery disease | Q82193757 | ||
Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke | Q83483859 | ||
Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke | Q85122825 | ||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e813 | |
P577 | publication date | 2015-05-01 | |
P1433 | published in | Medicine | Q15716652 |
P1476 | title | Peripheral frequency of CD4+ CD28- cells in acute ischemic stroke: relationship with stroke subtype and severity markers | |
P478 | volume | 94 |
Q37714724 | Assessed and Emerging Biomarkers in Stroke and Training-Mediated Stroke Recovery: State of the Art. |
Q49487950 | Association of apolipoprotein E genotype with outcome in hospitalized ischemic stroke patients |
Q36247545 | Characterization of Peripheral Immune Cell Subsets in Patients with Acute and Chronic Cerebrovascular Disease: A Case-Control Study |
Q37205886 | Early High-dosage Atorvastatin Treatment Improved Serum Immune-inflammatory Markers and Functional Outcome in Acute Ischemic Strokes Classified as Large Artery Atherosclerotic Stroke: A Randomized Trial. |
Q55618499 | Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke. |
Q92811619 | Growth Hormone Promotes Motor Function after Experimental Stroke and Enhances Recovery-Promoting Mechanisms within the Peri-Infarct Area |
Q64105803 | HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke |
Q55334485 | HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis. |
Q36010610 | High CD3+ Cells in Intracranial Thrombi Represent a Biomarker of Atherothrombotic Stroke |
Q47095847 | Hypertonic saline for prevention of delirium in geriatric patients who underwent hip surgery |
Q36194323 | Increased Risk of Hemorrhagic and Ischemic Strokes in Patients With Splenic Injury and Splenectomy: A Nationwide Cohort Study |
Q55666115 | Increased Soluble CD137 Levels and CD4+ T-Cell-Associated Expression of CD137 in Acute Atherothrombotic Stroke. |
Q37696815 | Increased risk of stroke in contact dermatitis patients: A nationwide population-based retrospective cohort study |
Q52149539 | Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes. |
Q50935230 | Inhibition of Peripheral TNF-α and Downregulation of Microglial Activation by Alpha-Lipoic Acid and Etanercept Protect Rat Brain Against Ischemic Stroke. |
Q47909309 | Kinin B1 receptor as a novel, prognostic progression biomarker for carotid atherosclerotic plaques |
Q28066324 | Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke |
Q64071804 | Neuroprotective Effects of Ginsenosides against Cerebral Ischemia |
Q38635300 | New insights about the putative role of myokines in the context of cardiac rehabilitation and secondary cardiovascular prevention. |
Q60308237 | Observational study of the status of coronary risk biomarkers among Negritos with metabolic syndrome in the east coast of Malaysia |
Q60516673 | Peripheral Frequency of CD4+ CD28− Cells in Acute Ischemic Stroke |
Q47712203 | Present Status and Future Challenges of New Therapeutic Targets in Preclinical Models of Stroke in Aged Animals with/without Comorbidities |
Q64233460 | Protective effect of remote ischemic pre-conditioning on patients undergoing cardiac bypass valve replacement surgery: A randomized controlled trial |
Q40646870 | Reduced Serum Level of Interleukin-10 is Associated with Cerebral Infarction: A Case-Control and Meta-Analysis Study |
Q52684105 | Relationship between serum vitamin D levels and inflammatory markers in acute stroke patients. |
Q48932827 | Renal Dysfunction, CHADS2 Score, and Adherence to the Anticoagulant Treatment in Nonvalvular Atrial Fibrillation |
Q38642771 | Serum resistin as an independent marker of aortic stiffness in patients with coronary artery disease. |
Q47823960 | Study on the mechanism of JAK2/STAT3 signaling pathway-mediated inflammatory reaction after cerebral ischemia. |
Q47874264 | Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke |
Q52677306 | Synergistic Effects of Salvianolic Acid B and Puerarin on Cerebral Ischemia Reperfusion Injury. |
Q88542904 | The HindIII and PvuII polymorphisms of lipoprotein lipase (LPL) gene reduce the risk of ischemic stroke (IS): A meta-analysis |
Q36448164 | Tumor necrosis factor-alpha (- 308G/A, + 488G/A, - 857C/T and -1031 T/C) gene polymorphisms and risk of ischemic stroke in north Indian population: A hospital based case-control study |
Q58598299 | Value of using the international classification of functioning, disability, and health for stroke rehabilitation assessment: A multicenter clinical study |
Q55365267 | Which aortic clamp strategy is better to reduce postoperative stroke and death: Single center report and a meta-analysis. |
Search more.